Practical aspects of the use of target controlled infusion with remifentanil in neurosurgical patients: predicted cerebral concentrations at intubation, incision and extubation

Acta Anaesthesiol Belg. 2006;57(3):265-70.

Abstract

Remifentanil has important side effects and it is not easy to know what remifentanil concentrations should be used during different endpoints of anaesthesia. We analyzed the remifentanil predicted effect-site concentrations (RemiCe) at different events during neurosurgical procedures and assessed if the concentrations used were clinically adequate. BIS and haemodynamic parameters were collected every 5 seconds. Predicted cerebral concentration of propofol (PropCe) and RemiCe were analyzed immediately prior to respective stimulus, and 30, 60 and 90 seconds after. RemiCe were 2.2 +/- 0.3, 6 +/- 2.6 and 2.2 +/- 0.9 ng ml(-1) at intubation, incision and extubation, respectively. PropCe observed in the same periods were 5 +/- 1, 2.6 +/- 0.9 and 1 +/- 0.3 microg ml(-1), also respectively. The remifentanil concentrations used in our patients were lower than reported concentrations, while being clinically adequate to minimize the haemodynamic response to stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anesthesia, General*
  • Anesthetics, Intravenous / administration & dosage*
  • Anesthetics, Intravenous / pharmacokinetics
  • Blood Pressure / drug effects
  • Brain / metabolism*
  • Drug Delivery Systems*
  • Electroencephalography / drug effects
  • Female
  • Heart Rate / drug effects
  • Humans
  • Infusions, Intravenous
  • Intubation, Intratracheal
  • Male
  • Middle Aged
  • Neurosurgical Procedures*
  • Piperidines / administration & dosage*
  • Piperidines / pharmacokinetics
  • Propofol
  • Remifentanil

Substances

  • Anesthetics, Intravenous
  • Piperidines
  • Remifentanil
  • Propofol